Back to Journals » Journal of Hepatocellular Carcinoma » Volume 12

Journal of Hepatocellular Carcinoma

COPE logo
ISSN: 2253-5969

Archive: Volume 12, 2025

Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint Inhibition

Lüdemann WM, Kahn J, Herzler P, Collettini F, Savic LJ, Mohr R, Fehrenbach U, Auer TA, Gebauer B, Amthauer H, Wieners G

Journal of Hepatocellular Carcinoma 2025, 12:1-13

Published Date: 3 March 2026

Research Hotspots of Traditional Chinese Medicine for Liver Cancer in the Future Directions: A Bibliometric Analysis

Liu Z, Zhang T, Xue CM, Zhang WT, Zhu BC, Hua GD

Journal of Hepatocellular Carcinoma 2025, 12:3105-3161

Published Date: 31 December 2025

Prognostic Role of Mitotic Index in Hepatocellular Carcinoma: Potential Clinical Implications for Very Early Stage Disease

Choi S, Cho YA, Park S, Koh HH, Park B, Kim K, Yang JD, Ha SY

Journal of Hepatocellular Carcinoma 2025, 12:3077-3090

Published Date: 30 December 2025

Nationwide Prevalence of Hepatocellular Carcinoma in Saudi Arabia: A Population-Based Analysis for 2021

De Vol EB, Bazarbashi S, Aseafan M, Aleid HS, Alnajem A, Alqahtani SA, Alqahtani A

Journal of Hepatocellular Carcinoma 2025, 12:3063-3076

Published Date: 30 December 2025

Combining Transarterial Chemoembolization with Sorafenib Improves Survival in Selected Patients with Hepatocellular Carcinoma and Extrahepatic Spread: A Multicenter Real-World Study

Yuan Y, Qiao Y, Zhu Y, Guo P, Gou J, Liu K, Wang L, Zhao S, Zhang Y, Liu Y, Wang E, Liu L

Journal of Hepatocellular Carcinoma 2025, 12:3049-3062

Published Date: 30 December 2025

CDCA3 Regulates Tumor-Associated Macrophages Polarize to Promote the Malignant Progression of Hepatocellular Carcinoma

Lyu S, Wang E, Lyu J, Xu H, Zhang D, Fang Z, Zhang L

Journal of Hepatocellular Carcinoma 2025, 12:3029-3047

Published Date: 28 December 2025

A Grading System of Intratumoral Tertiary Lymphoid Structure for Combined Hepatocellular-Cholangiocarcinoma: A Multicenter Pathological Study

Wang H, Qian YW, Zhao Y, Sheng X, Xia CY, Chen HZ, Cong WM, He MX, Dong H

Journal of Hepatocellular Carcinoma 2025, 12:3011-3027

Published Date: 25 December 2025

Construction of 3D Enhanced CT Radiomics-Based Model to Predict Circadian Gene Expression and Prognosis in Hepatocellular Carcinoma

Zhao J, Zhou H, Wang C, Zhang W, Pang Y, Zheng H, Zhang L, Zhou J, Hu Z

Journal of Hepatocellular Carcinoma 2025, 12:2989-3009

Published Date: 25 December 2025

TACE-HAIC Plus Targeted Therapy and Immunotherapy for HCC with Tumor Thrombus and Arteriovenous Fistula

Youtube play button
Youtube thumbnail

Liu X, Yin L, Liu B, Hou X, Li Y, Liu R

Journal of Hepatocellular Carcinoma 2025, 12:2951-2969

Published Date: 24 December 2025

Prognostic Significance and Mechanistic Insights of Rutin-Related Ferroptosis Gene Signature in Hepatocellular Carcinoma

Yao W, Li H, Zhang Y, Xia X, Wang H, Zhang Z, Shi D

Journal of Hepatocellular Carcinoma 2025, 12:2919-2937

Published Date: 23 December 2025

Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics

Hassan M, Hussain I, Ahmad K, Zafar S, Khalid A, Haseeb M, Hussain N, Ghafar MA

Journal of Hepatocellular Carcinoma 2025, 12:2907-2918

Published Date: 24 December 2025

Combined TACE and Microwave Ablation for Recurrent Spiegel-Lobe HCC: A Four-Case Series

Guan X, Hou R, Han Z, Piao X, Zhang S

Journal of Hepatocellular Carcinoma 2025, 12:2839-2844

Published Date: 19 December 2025

Transcatheter Arterial Chemoembolization May Be Selectively Indicated as Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients with Microvascular Invasion

Zeng J, Huang H, Tang M, Tao Z, Mo K, Chen W, Su Y, Su J, Liang R, Lin Y, Li L, Wu G, Luo X, Ye J, Mai R

Journal of Hepatocellular Carcinoma 2025, 12:2825-2838

Published Date: 18 December 2025

The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study

Youtube play button
Youtube thumbnail

Bayram D, Erdat EC, Özsan Çelebi SN, Türk S, Sekmek S, Perkin P, Aktürk Esen S, Uçar G, Şendur MAN, Uncu D, Köş FT, Civelek B

Journal of Hepatocellular Carcinoma 2025, 12:2811-2823

Published Date: 18 December 2025

BRAP Promotes the Tumorigenesis of Hepatocellular Carcinoma by Corrupting Cancer Cell Cycle Regulation and Enhancing Immune Evasion

Guo Y, Gu R, Gao F, Liu L, Deng D, Zhang Q, Wang L, Liu Q, Lan L, Cang S

Journal of Hepatocellular Carcinoma 2025, 12:2771-2793

Published Date: 16 December 2025

Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma

Eid JR, Yalciner M, Xiao L, Sun R, Kannan MK, Hassan M, Rashid A, Chamseddine S, Tran Cao HS, Amin HM, Kaseb AO

Journal of Hepatocellular Carcinoma 2025, 12:2709-2722

Published Date: 10 December 2025

Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatocellular Carcinoma and Its Correlation with Immune Infiltration

Aimaiti M, Maimaitituxun D, Yilihaer X, Kuerban T, Zhu J, Ainiwaer M, Jia Z, Abudourousuli A

Journal of Hepatocellular Carcinoma 2025, 12:2693-2707

Published Date: 11 December 2025

Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study

Luo WL, Wang QB, Li YK, Liang YB, Li J, Chen XM, Lakang Y, Yang ZS, Zuo JX, Wang W, Li SX, Ke Y

Journal of Hepatocellular Carcinoma 2025, 12:2681-2692

Published Date: 5 December 2025

Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma [Corrigendum]

Lu X, Wang Y, Yu Y, Zhang R, Long F, Li M, Pan M, Du K, Tan J, He J, Li Z, Lin H, Li M

Journal of Hepatocellular Carcinoma 2025, 12:2679-2680

Published Date: 5 December 2025

Gastropleural Fistula Following Combined TACE, Immunotherapy, and Bevacizumab in HCC: A Case Report

Xu X, Li J, Pan L, Yu H, Huang J

Journal of Hepatocellular Carcinoma 2025, 12:2671-2677

Published Date: 3 December 2025

Intensity-Modulated Proton Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

Liu CM, Lai CH, Wang YM, Huang EY, Chen YH, Ou HY, Hu TH, Hung CH, Lu SN, Chen WY, Huang BS, Cheng JY

Journal of Hepatocellular Carcinoma 2025, 12:2655-2670

Published Date: 1 December 2025

Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma

Lu CH, Chang CW, Chen SC, Kao WY, Ting WY, Lu CH, Chuang KI, Ni CF, Hsieh YY, Wu MS, Su CW, Chang CC, Wu CH

Journal of Hepatocellular Carcinoma 2025, 12:2625-2637

Published Date: 25 November 2025

Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study

Kang M, Cha WC, Sinn DH, Jeong WK, Kim DY, Lee MJ, Lim S, Kim D, Kim KP, Ryoo BY, Choi WM, Kim KM, Kim KH, Lee D, Choi EJ, Jung C, Kim J, Hong JY

Journal of Hepatocellular Carcinoma 2025, 12:2611-2623

Published Date: 25 November 2025

CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After Hepatectomy

Lei Y, Bai Y, Su Y, Bai X, Wang Y, Zheng C

Journal of Hepatocellular Carcinoma 2025, 12:2585-2598

Published Date: 19 November 2025

Integrative Multi-Omics and Functional Validation Reveal the Role of the TACE Refractoriness-Associated Gene ATP1B3 in Hepatocellular Carcinoma

Zhang C, Hu Q, Meng H, Wu Q, Zeng L, Zheng L, Weng Q, Qiu R, Xu M, Chen M, Chen F, Zhao Z, Yang Y, Ji J

Journal of Hepatocellular Carcinoma 2025, 12:2565-2583

Published Date: 19 November 2025

ARID3A Promotes Tumor Progression by Activating TNF-α/NF-κB Signaling in Dual-Phenotype Hepatocellular Carcinoma

Li M, Yang T, Huang J, Wu X, Chen J, Li J, Shi B, Zhang J, Xiang B

Journal of Hepatocellular Carcinoma 2025, 12:2553-2564

Published Date: 19 November 2025

sCD36 as a Biomarker for Progression and Recurrence in Type 2 Diabetes Mellitus Associated Hepatocellular Carcinoma

Dai W, Yang F, Guo F, Ding Y, He D, Zhang J, Guo Y, Gao Y, Xiao A

Journal of Hepatocellular Carcinoma 2025, 12:2541-2552

Published Date: 14 November 2025

Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents?

Guo H, Chen X, Li R, Shen J, Gan D, Yin Y, Zhang H, Xie J, Xie L, Liu Y

Journal of Hepatocellular Carcinoma 2025, 12:2513-2540

Published Date: 7 November 2025

Risk Factors for Recurrence in Patients with Hepatocellular Carcinoma After Curative Resection or Ablation

Meng F, Wang J, Zhu XD, Zhang M, Zhang X, Cheng D, Zhang X, Liu L

Journal of Hepatocellular Carcinoma 2025, 12:2501-2511

Published Date: 6 November 2025

ANT Score Nomogram for Predicting Very Early Recurrence of Hepatocellular Carcinoma

Yu Z, Wang H, Huo Q, Cao W, Jin L, Liu J, Wei F

Journal of Hepatocellular Carcinoma 2025, 12:2477-2490

Published Date: 5 November 2025

Cms1 Ribosomal Small Subunit Homolog Promotes HCC Proliferation and Migration by Modulating the TNF/NF-κB Signaling Pathway

Zhang T, Huang Y, Hu S, Yu Y, Qin F, Zhang Y, Cai Z, Wang H, Zhang P, Dai J

Journal of Hepatocellular Carcinoma 2025, 12:2429-2443

Published Date: 28 October 2025

Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma

Mai RY, Tao Z, Huang HY, Zeng C, Mo KX, Zeng DD, Liang R, Lin Y, Wang XB, Bai T, Li LQ, Ye JZ, Wu GB

Journal of Hepatocellular Carcinoma 2025, 12:2407-2419

Published Date: 27 October 2025

The Long Non-Coding RNA SNHG16 Negatively Regulates Let-7 and Predicts Recurrence in Hepatocellular Carcinoma

Shi W, Dong J, Li H, Jing L, Guo H, Liu T, Li C, Gao Y

Journal of Hepatocellular Carcinoma 2025, 12:2393-2406

Published Date: 23 October 2025

Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study

Chen X, Xing J, Zhang B, Peng W, Huang Z, Zhu T, Liu L, Liu X, Wan X, Mao Y, Chang X, Zhou K, Pan J, Hu D, Tan H, Zhang Y, Guan M, Du S

Journal of Hepatocellular Carcinoma 2025, 12:2379-2391

Published Date: 21 October 2025

P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACE

Attia A, Elshimi EA, Seif Eldin ZM, Rady MAM, Alkhatib A, Gomaa AI, Fouad TR, Waked I

Journal of Hepatocellular Carcinoma 2025, 12:2369-2378

Published Date: 21 October 2025

Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication

Hsu WF, Lo CC, Tseng KC, Lai HC, Chen CY, Peng CY

Journal of Hepatocellular Carcinoma 2025, 12:2327-2339

Published Date: 13 October 2025

Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma

Lu X, Wang Y, Yu Y, Zhang R, Long F, Li M, Pan M, Du K, Tan J, He J, Li Z, Lin H, Li M

Journal of Hepatocellular Carcinoma 2025, 12:2307-2325

Published Date: 13 October 2025

Prognostic Value of Clinical and CT Features in Camrelizumab Plus Apatinib Treatment for Unresectable Hepatocellular Carcinoma

Che J, Chen Y, Zeng Z, Li C, Zhang L, Huang X, Huang F, Wang Y, Huang W, Song B, Long L

Journal of Hepatocellular Carcinoma 2025, 12:2279-2293

Published Date: 9 October 2025

MRI-Based Deep Learning and Radiomics Nomogram for Predicting Hepatocellular Carcinoma Recurrence Within Six Months After Thermal Ablation

Chen Y, Zhao Y, Guan W, Wu D, Zheng L, Chen C, Geng X, Qi H, Song HY, Hu H

Journal of Hepatocellular Carcinoma 2025, 12:2247-2261

Published Date: 6 October 2025

Early PIVKA-II Response Associated with Treatment Efficacy and Survival Outcomes for Patients with Advanced Hepatocellular Carcinoma Receiving Immune Checkpoint Inhibitors and Targeted Therapy

Fang ZK, Xiao YT, Feng X, Shi ZJ, Liu SY, Yu Y, Jin LM, Huang DS, Zhang CW, Liu JW, Liang L

Journal of Hepatocellular Carcinoma 2025, 12:2235-2246

Published Date: 2 October 2025

Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study

Leng Z, Zhu T, Huang Z, Chen X, Lu Y, Zhang Y, Wan X, Yang X, Zhang L, Zhao H, Du S, Zhao Z, Zheng Y

Journal of Hepatocellular Carcinoma 2025, 12:2213-2224

Published Date: 30 September 2025

CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma

Ren L, Chen D, Xu T, Wei R, Zhao B, Zhou Y, He Y, Liao M, Chen H, Liao W

Journal of Hepatocellular Carcinoma 2025, 12:2183-2196

Published Date: 29 September 2025

A Refined Prognostic Model for Postoperative Overall Survival in Hepatocellular Carcinoma Based on CODEX-Based Multiproteomics and Radiomics

Wu Y, Wu J, Duan S, Liu D, Liu W, Song K, Zhang J, Feng Y, Zhang S, Liu Y, Dong H, Zhang H, Chen L, Jia N

Journal of Hepatocellular Carcinoma 2025, 12:2169-2182

Published Date: 26 September 2025

Low Indoleamine 2,3-Dioxygenase 1 Expression Enhances Dendritic Cells Response to Tumor Cells Against Hepatocellular Carcinoma

Mo C, Hong M, Li Y, Huang D, Ji Q, Liu Y

Journal of Hepatocellular Carcinoma 2025, 12:2149-2167

Published Date: 20 September 2025

Methodological Quality of Systematic Reviews on Treatments for Liver Cancer: A Cross-sectional Study

Cheng BZZ, Wang BH, Zhong CC, Zhang Y, Ho FF, Chung VC

Journal of Hepatocellular Carcinoma 2025, 12:2109-2121

Published Date: 16 September 2025

Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study

Wang QB, Luo WL, Li YK, Li J, Yang ZS, Zhao K, Lakang Y, Liang YB, Chen XM, Zuo JX, Duan Y, Xu X, Shang LM, Ke Y

Journal of Hepatocellular Carcinoma 2025, 12:2055-2067

Published Date: 12 September 2025

Radiation-Induced Liver Injury: An Overview

Sun J, Lu HR, Wu JH, Li D, Zhang T, Duan XZ

Journal of Hepatocellular Carcinoma 2025, 12:2045-2054

Published Date: 10 September 2025

Prognostic Significance of Liquid Biopsy-Detected Genetic Alterations in Hepatocellular Carcinoma

Youtube play button
Youtube thumbnail

Sarıtaş AG, Yavuz B, Aydın İ, Ağca H, Topal U, Ballı T, Bisgin A, Ülkü A, Akçam AT

Journal of Hepatocellular Carcinoma 2025, 12:2035-2043

Published Date: 5 September 2025

Newly Established Anoikis-Associated Genes Predict the Prognosis of Hepatocellular Carcinoma

Li Y, Li E, Zheng W, Shi J, Yu S, Zhang X, Zheng L, Du W, Liu H, Feng H, Guo J, Yu Z

Journal of Hepatocellular Carcinoma 2025, 12:2017-2034

Published Date: 3 September 2025

Efficacy and Safety of Different Doses of Bevacizumab Combined with Atezolizumab in Unresectable Hepatocellular Carcinoma

Zhang S, Wang J, Zhu Z, Ji P, Wang Y, Cheng K, Nashan B, Liu L, Zhang S

Journal of Hepatocellular Carcinoma 2025, 12:2007-2015

Published Date: 31 August 2025

Exploration of the Mechanism of Action of Dendrobium officinale in the Treatment of Liver Cancer Based on Network Pharmacology, Molecular Docking and in vitro Validation

Youtube play button
Youtube thumbnail

Zhan S, Lu X, Guo H, Liu Y, Li Z, Xu W, Xia F, Tang H, Tian Y, Chen J, Lin X

Journal of Hepatocellular Carcinoma 2025, 12:1973-1990

Published Date: 28 August 2025

Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Sintilimab Plus Bevacizumab Biosimilar in the Treatment of Unresectable Hepatocellular Carcinoma

Qin H, Jiang K, Liu C, Lin H, Xia J, Ya H, Gu J, Suo L, Li B, Deng X, Wang D, Huang X, Li S

Journal of Hepatocellular Carcinoma 2025, 12:1943-1955

Published Date: 27 August 2025

Screening Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Patients After Tyrosine Kinase Inhibitor Plus PD-1/PD-L1 Antibody Therapy: A Multicenter Retrospective Study

Jin Z, Li X, Lv L, Zhang B, Ma X, Chen S, You J, Wu X, Wang L, Liu X, Wang F, Chen X, Yu L, Zhang S, Zhang L

Journal of Hepatocellular Carcinoma 2025, 12:1921-1941

Published Date: 25 August 2025

Triple Therapy with Interventional Treatment, Donafenib, and Anti-PD-1 Antibodies in Unresectable Hepatocellular Carcinoma: A Retrospective Real-World Study in China

Ye Q, Song Z, Yu T, Li Y, Ai L, Yang G, Su K, Chen D, Zhao W, Ding R, Zha Y, Li G

Journal of Hepatocellular Carcinoma 2025, 12:1905-1919

Published Date: 24 August 2025

The Predictive Significance of Interleukin-2 Receptor in Patients with Hepatocellular Carcinoma

Tian Z, Guo Y, Yang R, Yang W

Journal of Hepatocellular Carcinoma 2025, 12:1893-1904

Published Date: 22 August 2025

ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma

Ding J, Zou X, Huang X, Yu L, Hong H, Lin T

Journal of Hepatocellular Carcinoma 2025, 12:1873-1892

Published Date: 21 August 2025

A Comparative Study of Five Large Language Models’ Response for Liver Cancer Comprehensive Treatment

Zhong D, Liang Y, Yan HT, Chen X, Yang Q, Ma S, Su Y, Chen Y, Huang X, Wang M

Journal of Hepatocellular Carcinoma 2025, 12:1861-1871

Published Date: 20 August 2025

A Patient Charter to Improve Care for Hepatocellular Carcinoma

Hassan Y, Kautz A, James C, Lee D, Langenbacher D, Bouffet E, Chakowa J, Hicks J, Ward JW, Kuschnereit LA, Allaire M, Zhang T, Huang Chi Z

Journal of Hepatocellular Carcinoma 2025, 12:1849-1859

Published Date: 20 August 2025

TACE Sequential to Radiofrequency Ablation versus RFA Alone in Hepatocellular Carcinoma Within Milan Criteria

Yan H, Zhao C, Liu M, Liu H, Mu L, Xiang Z, Huang M

Journal of Hepatocellular Carcinoma 2025, 12:1795-1805

Published Date: 12 August 2025

Whether Adjuvant TACE Plus TKI Therapy is More Effective Than TACE Alone in HCC Patients at High Risks of Recurrence Following Radical Hepatectomy

Li Y, Wang K, Qin H, Huo S, Jiang K, Xia J, Gu J, Ya H, Suo L, Wang D, Huang X, Li S

Journal of Hepatocellular Carcinoma 2025, 12:1767-1780

Published Date: 11 August 2025

Predictive Radiomics-Based Model for Recurrence-Free Survival After Curative Resection in Patients with Hepatocellular Carcinoma

Cui J, Lin Z, Huang X, Wang S, Guo J, Song J, Zhang S, Lv J, Qiu W

Journal of Hepatocellular Carcinoma 2025, 12:1755-1766

Published Date: 7 August 2025

Predictive Value of IDEAL-IQ and DWI Imaging Biomarkers for P53 Mutations in Hepatocellular Carcinoma

Wang D, Yin H, Li X, Zhou S, Wang YC

Journal of Hepatocellular Carcinoma 2025, 12:1743-1753

Published Date: 6 August 2025

Triphasic CT Radiomics Model for Preoperative Prediction of Hepatocellular Carcinoma Pathological Grading

Huang H, Pan X, Zhang Y, Yang J, Chen L, Zhao Q, Huang L, Lu W, Deng Y, Huang Y, Ding K

Journal of Hepatocellular Carcinoma 2025, 12:1725-1742

Published Date: 6 August 2025

Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular Carcinoma

Liu S, Xie Y, Li T, Huang Y, Xu D, Cai L, Fu Y, Chen J, Zhang Y, Huang J, Hu Z

Journal of Hepatocellular Carcinoma 2025, 12:1711-1723

Published Date: 5 August 2025

GALNT14 Genetic Variants Harbor Differential Prognostic Values Linking to Distinct Macrophage Cell Types in Hepatocellular Carcinoma

Chu YD, Ho PH, Chen WT, Shih YL, Lai MW, Hsu CW, Yeh CT

Journal of Hepatocellular Carcinoma 2025, 12:1695-1710

Published Date: 4 August 2025

Single-Cell RNA Sequencing Integrated with Bulk-RNA Sequencing Analysis Reveals Prognostic Signatures Based on PANoptosis in Hepatocellular Carcinoma

Wang J, Yin X, Li Z, Liang P, Wang Y, Li X, Qiao W, Xiong C, Yu M, Ding X, Wang X

Journal of Hepatocellular Carcinoma 2025, 12:1661-1676

Published Date: 29 July 2025

Distinct Roles of HHLA2 and PD-L1 in the Immune Cell and Prognosis of Hepatocellular Carcinoma

Wang CH, Chen SL, Yang X, Wu T, Liu LL, Yun JP

Journal of Hepatocellular Carcinoma 2025, 12:1633-1645

Published Date: 25 July 2025

Survival Outcomes and Prognostic Factors of Systemic Therapy for Advanced Hepatocellular Carcinoma: A Multidisciplinary Clinic Experience from Saudi Arabia

Asiri M, BinAbdu A, Al-Ammar A, Alsuaib AA, Al-Shehri A, Almazyad AA, Aloufi AM, AlGazlan N, Alrajih HS, Alkaiyat M, Ardah HI, Shehata H, Alshammari K

Journal of Hepatocellular Carcinoma 2025, 12:1623-1632

Published Date: 23 July 2025

Automatic Real-Time Detection and Diagnosis of Liver Tumor with Ultrasound

Wu CH, Sheu JC, Chou PL, Lee J, Nien HC

Journal of Hepatocellular Carcinoma 2025, 12:1599-1611

Published Date: 23 July 2025

Exploring Autophagy-Related Gene Expression in Hepatocellular Carcinoma via TCGA, GEPIA2, and HPA Databases: Implications for Prognosis

Gu X, Chen Y, Hu X, Li Y, Zhu R, Li H, Yuan Z, Wang Y

Journal of Hepatocellular Carcinoma 2025, 12:1557-1586

Published Date: 22 July 2025

Prognostic Value of Gd-BOPTA Enhanced MRI in Solitary Resected Hepatocellular Carcinoma Without Microvascular Invasion

Zhang J, Luo H, Li Y, Feng Y, Pan X, Ouyang B, Nian G, Jia N, Li Y

Journal of Hepatocellular Carcinoma 2025, 12:1471-1482

Published Date: 18 July 2025

Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma

Zhang J, Xu Y, Ni X, Mao Z, Xiao H, Chen M, Lin Y, Pan J, Zhang B, Zhang L, Zheng X, Song G, Ge N

Journal of Hepatocellular Carcinoma 2025, 12:1453-1469

Published Date: 17 July 2025

A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030

Lau-Min KS, Abrams T, Bullock A, Kaplan A, Salas Karnes L, Kennedy MW, LeBedis CA, Lin MV, McCleary NJ, Sioshansi S, Voligny E, Walsh EP, Manz CR

Journal of Hepatocellular Carcinoma 2025, 12:1417-1424

Published Date: 16 July 2025

Silencing NEDD4L Effectively Inhibits the Malignant Behaviors of Hepatocellular Carcinoma

Dai J, Zhu T, Wan J, Liu R, Song Y, Zhang D, Wang X, Zhang H, Li W, Lin J, Zhu X, Liu Y

Journal of Hepatocellular Carcinoma 2025, 12:1369-1391

Published Date: 10 July 2025

Hsa_circ_0007991 Promotes Immune Evasion in Hepatocellular Carcinoma via Regulation of the miR-505-3p/CANX Axis

Wang L, Liang L, Qian J, Yu C, Shi Y, Yan X, Chen X

Journal of Hepatocellular Carcinoma 2025, 12:1337-1351

Published Date: 7 July 2025

Multidisciplinary Team Management of Hepatocellular Carcinoma in the MENA Region: Current Practices, Challenges, and Gaps

El-Kassas M, Khalifa R, AlNaamani KM, Shousha H, Yilmaz Y, Sanai FM, Almattooq M, Labidi A, Akroush MWI, Debzi N, Abdelmalek MO, Abdeen NS, Tumi A, Elbadry M, El Fouly A, Marwan E, Al Suwaidi J, Elzouki AN, Alswat KA

Journal of Hepatocellular Carcinoma 2025, 12:1315-1335

Published Date: 8 July 2025

Hyper-Relapse Disease is a Special Pattern of Relapse of Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study

Yang ZL, Gan YX, Xu JX, Tang YH, Ouyang LY, Qi LN, Xu L

Journal of Hepatocellular Carcinoma 2025, 12:1301-1314

Published Date: 5 July 2025

Integrating CEUS Imaging Features and LI-RADS Classification for Postoperative Early Recurrence Prediction in Solitary Hepatocellular Carcinoma: A Machine Learning-Based Prognostic Approach

Liang L, Pang J, Zhang B, Que Q, Gao R, Wu Y, Peng J, Zhang W, Bai X, Wen R, He Y, Yang H

Journal of Hepatocellular Carcinoma 2025, 12:1287-1300

Published Date: 3 July 2025

Retrospective Multicentre Real-Life Study Evaluating the Efficacy of Atezolizumab Combined with Bevacizumab for the Treatment of Metastatic Hepatocellular Carcinoma: HIREAL Study

Barbe-Richaud JB, Moinard-Butot F, Husson-Wetzel S, Bolliet M, Chiappa P, Belletier C, Ribeiro M, Poprawa E, Bigot C, Abergel A, Ben Abdelghani M

Journal of Hepatocellular Carcinoma 2025, 12:1279-1286

Published Date: 1 July 2025

Clinical Outcomes of AFP-Negative Patients with Advanced HCC: A Propensity-Matched Analysis from a Retrospective Cohort Study

Liu X, Zhuang L, Yang F, Liu P, Xia Z, Guo Y, Dong P, Chen C, Li Z

Journal of Hepatocellular Carcinoma 2025, 12:1241-1252

Published Date: 27 June 2025

Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma

Chen PY, Chang CK, Chen BB, Hsu CH, Cheng AL, Shao YY

Journal of Hepatocellular Carcinoma 2025, 12:1221-1229

Published Date: 23 June 2025

Application of Robotic Surgery in Hepatocellular Carcinoma

Li PH, Ding ZW, Ye YQ

Journal of Hepatocellular Carcinoma 2025, 12:1217-1220

Published Date: 19 June 2025

In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma

Liang JD, Liang PC, Shun CT, Chen CH, Wu YM, Hsu YC, Lee YT, Yang PM, Huang GT, Salazar AM, Lee HS, Sheu JC, Weng MT

Journal of Hepatocellular Carcinoma 2025, 12:1191-1204

Published Date: 14 June 2025

Intravoxel Incoherent Motion Improves the Accuracy of Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma

Li M, Zhang G, Li J, Ren Y, Jin X, Ke Q, Guo C, Lv J, Lu H, Xu Y, Liang W, Quan X, Li X

Journal of Hepatocellular Carcinoma 2025, 12:1177-1190

Published Date: 11 June 2025

Genetic Variants of UGP2 and FBP2 in the Glycolysis Pathway Independently Predict Survival of Patients with HBV-Related Hepatocellular Carcinoma

Gong R, Qiu M, Liu Y, Cao J, Zhou Z, Lin Q, Jiang Y, Liang X, Wei Y, Wen Q, Chen P, Wei X, Wei J, Zhan S, Zhang R, Ye D, Yu H

Journal of Hepatocellular Carcinoma 2025, 12:1155-1166

Published Date: 7 June 2025

Factor Analysis of the Effect of Hepatitis B-Related Liver Cancer Treatment Efficacy

Liu SW, Zhou Y, Feng XY, Hai L, Ma WL, Ma LN, Ding XC, Luo X

Journal of Hepatocellular Carcinoma 2025, 12:1141-1154

Published Date: 5 June 2025

Predicting Resistance and Survival of HCC Patients Post-HAIC: Based on Shapley Additive exPlanations and Machine Learning

Yao F, Miao J, Quan B, Li J, Tang B, Lu S, Yin X

Journal of Hepatocellular Carcinoma 2025, 12:1111-1128

Published Date: 31 May 2025

Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma

Youtube play button
Youtube thumbnail

Song Z, Zheng X, Wang H, Dong D, Zhu X, Geng J, Li S, Song M, Du R, Zhang Y, Liu Z, Cai Y, Li Y, Wang W

Journal of Hepatocellular Carcinoma 2025, 12:1097-1110

Published Date: 31 May 2025

Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors: A Retrospective Analysis

Fu X, Jiang S, Li Y, Guo Y, Gong B, Lou J, Li Y, Wang S, Sun Y, Ren Y, Chen Q, Yang L

Journal of Hepatocellular Carcinoma 2025, 12:1069-1082

Published Date: 30 May 2025

Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study

Sun HC, Huang ZY, Wen T, Liu L, Zhu XD, Zhang E, Li C, Zhang X, Wang J, Fan J, Zhou J

Journal of Hepatocellular Carcinoma 2025, 12:1043-1056

Published Date: 22 May 2025

Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients

Liu CW, Lin PT, Teng W, Chen WT, Su CW, Hsieh YC, Lin CC, Lin CY, Lin SM

Journal of Hepatocellular Carcinoma 2025, 12:1017-1029

Published Date: 21 May 2025

Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study

Su K, Liu X, Zeng YC, Xu J, Li H, Wang H, Du S, Wang H, Yue J, Yin Y, Li Z

Journal of Hepatocellular Carcinoma 2025, 12:933-947

Published Date: 9 May 2025

Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-Stage Hepatocellular Carcinoma: A Multi-Institutional Cohort Study in an Asian Population

Chen HK, Chang KC, Shao SC, Soong RS, Chen YC, Wu CF, Wu TH, Chou TS, Chan SC, Lai ECC

Journal of Hepatocellular Carcinoma 2025, 12:879-890

Published Date: 7 May 2025

Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis

Munker S, Rodriguez I, Bernhart K, Ben Khaled N, Findik M, Siegmund LK, Ye L, Reiter FP, Roessler D, Nasseh D, Balcar L, Pomej K, Scheiner B, Weiss C, Pinter M, Seidensticker M, Mayerle J, Philipp AB, De Toni EN

Journal of Hepatocellular Carcinoma 2025, 12:855-864

Published Date: 5 May 2025

The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling

Wang Y, Tan H, Wen C, Chen S, Zheng G, Qi H, Xie L, Shen L, Cao F, Fan W

Journal of Hepatocellular Carcinoma 2025, 12:825-835

Published Date: 26 April 2025

A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma

Zhang Z, Zhao H, Wang P, Geng X, Yin M, Liu Y, Zhang S, Liang Y, Ji J, Zheng G

Journal of Hepatocellular Carcinoma 2025, 12:805-823

Published Date: 18 April 2025

Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network

Cosgrove D, Tan R, Osterland AJ, Hernandez S, Ogale S, Mahrus S, Murphy J, Wilson T, Patton G, Loaiza-Bonilla A, Singal AG

Journal of Hepatocellular Carcinoma 2025, 12:791-804

Published Date: 18 April 2025

Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit

Wu M, Zou F, He S, Pi Y, Song Y, Chen S, Li L

Journal of Hepatocellular Carcinoma 2025, 12:729-745

Published Date: 13 April 2025

Preoperative Prediction of Macrotrabecular-Massive Hepatocellular Carcinoma Using Machine Learning-Based Ultrasomics

Li Y, Duan S, Ren S, Li D, Ma Y, Bu D, Liu Y, Li X, Cai X, Zhang L

Journal of Hepatocellular Carcinoma 2025, 12:715-727

Published Date: 12 April 2025

Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning

Liu Q, Yang Y, Wang Y, Wei S, Yang L, Liu T, Yu Z, Feng Y, Yao P, Zhu Q

Journal of Hepatocellular Carcinoma 2025, 12:685-704

Published Date: 5 April 2025

ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab

Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D’Alessio A

Journal of Hepatocellular Carcinoma 2025, 12:671-683

Published Date: 4 April 2025

Machine Learning-Based Model Used for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B

Wu T, Yan J, Xiong F, Liu X, Zhou Y, Ji X, Meng P, Jiang Y, Hou Y

Journal of Hepatocellular Carcinoma 2025, 12:659-670

Published Date: 3 April 2025

The Expression of Ferroptosis-Related Genes in Hepatocellular Carcinoma and Their Relationships With Prognosis

Li H, Hu X, Wang L, Gu X, Chen S, Tang Y, Chen Y, Chen J, Yuan Z, Wang Y

Journal of Hepatocellular Carcinoma 2025, 12:629-648

Published Date: 20 March 2025

Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score

Fan W, Zheng X, Zhang W, Zhu B, Wu Y, Xue M, Tang R, Huang Z, Qiao L, Lu M, Wu J, Tang Y, Chen J, Huang S, Bai M, Li J

Journal of Hepatocellular Carcinoma 2025, 12:615-628

Published Date: 20 March 2025

Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study

Chen X, Wu X, Peng W, Liu L, Liu X, Wan X, Xu H, Zheng Y, Zhao H, Mao Y, Lu X, Sang X, Chang X, Zhou K, Pan J, Guan M, Hu D, Tan H, Zhang Y, Du S

Journal of Hepatocellular Carcinoma 2025, 12:561-577

Published Date: 19 March 2025

Radiation Segmentectomy or Ablative External Beam Radiation Therapy as Initial Treatment for Solitary Hepatocellular Carcinoma: A Multicenter Experience

De la Garza-Ramos C, Montazeri SA, LeGout JD, Lewis AR, Frey GT, Paz-Fumagalli R, Hallemeier CL, Rutenberg MS, Ashman JB, Toskich BB

Journal of Hepatocellular Carcinoma 2025, 12:553-559

Published Date: 13 March 2025

Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma

Zheng G, Zheng M, Hu P, Zhu Y, Zhang W, Zhang F

Journal of Hepatocellular Carcinoma 2025, 12:539-552

Published Date: 12 March 2025

The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer

Liu Y, Jiang W, Li X, Zhao H, Wang S

Journal of Hepatocellular Carcinoma 2025, 12:513-526

Published Date: 6 March 2025

Research Progress of Liver Cancer Recurrence Based on Energy Metabolism of Liver Cancer Stem Cells

Wu M, Wang H, Wu X, Zeng H, Miao M, Song Y

Journal of Hepatocellular Carcinoma 2025, 12:467-480

Published Date: 3 March 2025

Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon’s Perspective

Zhu XD, Zhao L, Li B, Cheng Y, Sun HC

Journal of Hepatocellular Carcinoma 2025, 12:399-413

Published Date: 26 February 2025

Application of Intravoxel Incoherent Motion in the Prediction of Intra-Tumoral Tertiary Lymphoid Structures in Hepatocellular Carcinoma

Ma L, Liao S, Zhang X, Zhou F, Geng Z, Hu J, Zhang Y, Zhang C, Meng T, Wang S, Xie C

Journal of Hepatocellular Carcinoma 2025, 12:383-398

Published Date: 22 February 2025

Coilin Affects the Prognosis of Hepatocellular Carcinoma Through Cell Cycle and Apoptosis

Lu L, Zhou X, Zheng J, Li D

Journal of Hepatocellular Carcinoma 2025, 12:367-382

Published Date: 21 February 2025

Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients

Zhu D, Tulahong A, Abuduhelili A, Liu C, Aierken A, Lin Y, Jiang T, Lin R, Shao Y, Aji T

Journal of Hepatocellular Carcinoma 2025, 12:353-365

Published Date: 19 February 2025

Outcomes and Prognostic Factors in Cirrhotic Patients with Acute Variceal Bleeding and Hepatocellular Carcinoma: A Nested Case–Control Study

Liu G, Xiao S, Xiang T, Wang X, Shen Y, Yang L, Luo X

Journal of Hepatocellular Carcinoma 2025, 12:343-352

Published Date: 19 February 2025

Comprehensive Analysis of the Role of Heat Shock Proteins in the Immune Microenvironment and Clinical Significance of Hepatocellular Carcinoma

Xiao H, Wang B, Xiong S, Li C, Ding Y, Chao D, Mei B, Shen N, Luo G

Journal of Hepatocellular Carcinoma 2025, 12:325-342

Published Date: 17 February 2025

Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma

Li Y, Lu R, Abuduhailili X, Feng Y

Journal of Hepatocellular Carcinoma 2025, 12:301-324

Published Date: 17 February 2025

Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States

Finn RS, Iyer R, Kalman RS, Parikh ND, Cabrera R, Babajanyan S, Kaseb AO

Journal of Hepatocellular Carcinoma 2025, 12:231-246

Published Date: 7 February 2025

Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant

Zhang S, Song R, Hou C, Yao H, Xu J, Zhou H, Li S, Cai W, Fei Y, Meng F, Yin D, Wang J, Zhang S, Liu Y, Wang J, Liu L

Journal of Hepatocellular Carcinoma 2025, 12:219-229

Published Date: 5 February 2025

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma

Youtube play button
Youtube thumbnail

Wang W, Zhang Q, Cui Y, Zhang S, Li B, Xia T, Song Y, Zhou S, Ye F, Xiao W, Cao K, Chi Y, Qu J, Zhou G, Chen Z, Zhang T, Chen X, Ju S, Wang YC

Journal of Hepatocellular Carcinoma 2025, 12:193-203

Published Date: 29 January 2025

The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection

Yu ZC, Fang ZK, Yu Y, Liu SY, Wang KD, Shi ZJ, Jin LM, Huang XK, Lu Y, Shen GL, Liu JW, Huang DS, Zhang CW, Liang L

Journal of Hepatocellular Carcinoma 2025, 12:183-192

Published Date: 30 January 2025

Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus

Li X, Cao K, Fu Z, Chen X, Zhong J, Liu L, Ding N, Zhang X, Qu Z, Zhu L, Zhai J

Journal of Hepatocellular Carcinoma 2025, 12:169-182

Published Date: 25 January 2025

Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular Carcinoma

Zhong L, Peng W, Sun J, Luo Y, Sheng H, Wu Y, Zhou T, Zhou C, Cao C

Journal of Hepatocellular Carcinoma 2025, 12:123-134

Published Date: 22 January 2025

A New Risk Score Based on Lipid Indicators for Patients with Advanced Hepatocellular Carcinoma

Wei X, Guo Z, Zhang T, Liang J

Journal of Hepatocellular Carcinoma 2025, 12:107-121

Published Date: 21 January 2025

Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus

Hatia RI, Hwang LY, Li R, Troisi C, Jalal PK, Amos CI, Gomez HF, Chun YS, Rashid A, Kaseb AO, Scheet PA, Hassan MM

Journal of Hepatocellular Carcinoma 2025, 12:93-106

Published Date: 21 January 2025

A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE

Wu L, Chen L, Zhang L, Liu Y, Ouyang D, Wu W, Lei Y, Han P, Zhao H, Zheng C

Journal of Hepatocellular Carcinoma 2025, 12:77-91

Published Date: 21 January 2025

Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma

Song Y, Tian S, Li Z, Miao J, Wu M, Xu T, Wu X, Qiao J, Zhang X, Zhao H, Kang L, Cao L, Zhu P, Miao M

Journal of Hepatocellular Carcinoma 2025, 12:59-76

Published Date: 18 January 2025

Prediction of Pathologic Response in Unresectable Hepatocellular Carcinoma After Downstaging with Locoregional and Systemic Combination Therapy

Yang C, Chen Y, Sheng L, Wang Y, Zhang X, Yang Y, Ronot M, Jiang H, Song B

Journal of Hepatocellular Carcinoma 2025, 12:43-58

Published Date: 16 January 2025

Fully Covered Stent-TIPS for Advanced HCC Patients with Portal Vein Tumor Thrombus-Related Severe Symptomatic Portal Hypertension

Liu Z, Lyu T, Yang J, Xie Y, Fan S, Song L, Zou Y, Wang J

Journal of Hepatocellular Carcinoma 2025, 12:29-41

Published Date: 14 January 2025